From Breakthroughs Blog: HIV/AIDS

 
Play: TRICK or TREATment?

To enjoy a bit of fun and mischief this Halloween, we’ve created a game, TRICK or TREATment, to test our readers’ knowledge of global health technologies.

Read More
PATH/Satvir Malhotra
Research Roundup: Global Fund replenishment, FDA allows marketing of first rapid Ebola test, and NIH to launch influenza vaccine research centers

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Doune Porter
Research Roundup: Kenya 3rd country to roll out malaria vaccine, scientists gene-edit stem cells to treat HIV, and an affordable new test for dengue

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Patrick McKern
Research Roundup: WHO releases findings from malaria eradication report, two-month HIV injection could be on its way, and refrigerator to protect vaccines against power outages

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Gabe Bienczycki
Research Roundup: A 'Google' for biomedical data, alarming surge in drug-resistant HIV, and CEPI partners with Valneva to develop Chikungunya vaccine

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Carib Nelson
Research Roundup: WHO recommends dolutegravir as the first-choice HIV treatment, an arm implant that may one day protect against HIV, and malaria drugs failing in Southeast Asia

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Gabe Bienczycki
Research Roundup: Wiping out mosquitoes on two Chinese islands, betting on biometrics to boost vaccination rates, and J&J to test HIV vaccine in US and Europe

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Patrick McKern
Research Roundup: a two-drug HIV treatment found equally effective as three drugs, experimental Ebola treatments show promise in lab study, and WHO upgrades list of essential diagnostic tests

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Patrick McKern
Research Roundup: GARDP to develop 5 new treatments for antibiotic resistant infections by 2025, researchers eliminated HIV from DNA of infected mice, and G20 leaders commit to advance global health

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Satvir Malhotra
Research Roundup: Contraceptives and HIV trial, identification of protective antibodies may be key to malaria vaccine, and Drug Transparency Observatory launched In France

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Georgina Goodwin
Research Roundup: An experimental Ebola cure may also protect against Nipah virus, gender inequality in clinical trials, and FDA authorizes first Zika diagnostic test for marketing

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Gabe Bienczycki
Innovating the way towards UHC at WHA

Universal health coverage (UHC) will take center stage at the World Health Assembly later this month. While there are many building blocks to achieve UHC, one integral pillar that is too often overlooked is innovation—the creation of new and improved drugs, vaccines, and diagnostic tools. Global health research and development is indispensable in delivering on the vision of quality health for all.

GHTC
Read More
PATH/Wendy Stone
Research Roundup: Study finds drugs stop HIV transmission, polio endgame strategy includes new technologies and vaccines, and FDA approves first ever vaccine for dengue fever

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
Members of Congress push back at President’s budget cuts to global health research

The Trump administration’s budget request for fiscal year 2020 (FY20) includes cuts that—if enacted—would hamstring the research and development (R&D) of new global health technologies. Since the release of the budget request in early March, however, lawmakers from both parties have expressed their commitment to shielding critical funding strings from the president’s scissors.

Read More
PATH/Satvir Malhotra
Research Roundup: WHO emergency panel meets about Ebola in DRC, new study reveals HIV vulnerabilities, and how Global Health Investment Fund is revolutionizing impact investing

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Eric Becker
Research Roundup: WHO transformations, new funding model for health needed, and HIV reported cured in second patient

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Algy Amad
Research Roundup: Pregnant women in DRC to be given Ebola vaccine, releases of genetically modified mosquitoes in high-security lab, and CRISPR may help against viruses for which no vaccine exists

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Wendy Stone
Research Roundup: New funding partnership to develop drugs for leishmaniasis, an atlas of HIV mutations could improve vaccine design, and a high-tech pill could end drug injections

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
Flickr/Craig Fildes
State of the Union HIV pledge links a “once-distant dream” to “scientific breakthroughs”

On February 5, President Trump delivered his second State of the Union address. Among the long list of policy proposals and pledges in the speech was one of great interest to the global health research community—an announcement of a new whole-of-government plan to eliminate HIV transmission in the United States by 2030.

Read More
PATH/Jennifer Fox
As America leads, other nations step up to fund R&D to combat neglected disease threats

The US government has long played an indispensable role in driving global health progress as the world’s leading funder of research and development (R&D) for new vaccines, treatments, and other tools to fight neglected diseases.

Read More
PATH/Mike Wang
Research Roundup: UK vaccine center to help fight epidemics, global map of HIV reveals vaccine challenges, and researchers create antibodies to test and treat Zika

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Patrick McKern
Research Roundup: Male birth control one step closer to reality, three-in-one HIV drug launched, and powdered polio vaccine brings new hope

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Matthew Dakin
Research Roundup: Access to Medicines index released, clinical trial of injectable ARV, and Zika vaccine clears early trial

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Satvir Malhotra
Research Roundup: Effective experimental Ebola treatments, once-monthly injection to suppress HIV, and malaria-detecting dogs

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Gabe Bienczycki
Research Roundup: Suppository drug cuts child malaria deaths, J&J touts latest immune response data for 'mosaic' HIV vaccine program, and game changer TB drug

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
Flickr/macwagen
Play: TRICK or TREATment?

To enjoy a bit of fun and mischief this Halloween, we’ve created a new game, TRICK or TREATment, to test our readers’ knowledge of global health technologies.

Read More
PATH/Satvir Malhotra
Research Roundup: Metagenomics sequencing, combinations of antibodies that suppress HIV, and a partnership to reduce child deaths from AMR

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Wendy Stone
Research Roundup: Long-acting HIV drugs, a universal flu vaccine candidate, and a low-cost device in the fight against malaria

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Patrick McKern
Research Roundup: R&D investment in Africa, genetically modified rice to help prevent HIV, and antibodies for three Ebola viruses

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Patrick McKern
Research Roundup: Congo confirms the end of its Ebola outbreak, new treatments for HIV and malaria

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Georgina Goodwin
Research Roundup: An HIV vaccine shows promise, Paraguay conquers malaria, and tackling malaria using veterinary drugs

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Gabe Bienczycki
Health R&D saves lives, spurs innovation, and solidifies success

USAID’s latest report to Congress demonstrates how strategic R&D investments are driving positive global health outcomes and saving American taxpayers money

Read More
PATH/Patrick McKern
Research Roundup: New breakthroughs in HIV and TB-detection research and 17 brave volunteers

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Patrick McKern
Research Roundup: New work in malaria and HIV diagnostics and a widespread immunization campaign in Brazil

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Wendy Stone
Research Roundup: Discovering new antibiotics in soil and harnessing gene therapy to fight AIDS

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Georgina Goodwin
Research Roundup: Stem cells and TB, the research agenda to end malaria, and a monkey species role in ending AIDS

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Aaron Joel Santos
Five issues to watch in US global health R&D policy in 2018

2018 is shaping up to be another important year for US policy related to global health and medical research. As Congress returns for a busy work session and the White House continues to roll out policy reforms, here are the top five issues GHTC will be following in 2018.

GHTC
Read More
PATH/Lynn Heinisch
Research Roundup: Improved Ebola & malaria diagnostics and gene therapy to foster HIV immunity

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Sanofi Pasteur / Patrick Boulen
A year in review: The global health innovation stories that shaped 2017

As the year comes to an end, GHTC is reflecting on the top stories in global health innovation that made news in 2017.

Read More
Celebrating ten years of GHTC & a decade of progress in global health innovation

As we close out our 10th anniversary year, we wanted to take a moment to reflect on our shared progress and celebrate the headlines and moments that shaped global health R&D over the past decade. Check out some of the highlights...

Read More
PATH/Mike Wang
Research Roundup: A powerful single-dose Cholera vaccine, breakthrough in understanding the malaria parasite, and a rapid urine test for TB

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: Dangers of immune response to Zika, curbing HIV/AIDS severity, and a potential leishmaniasis vaccine

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week

GHTC
Read More
CDC/ Sue Partridge, CDC- Ft. Collins
Research Roundup: Global immunization, Zika diagnostics, and an HIV treatment milestone

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Heng Chivoan
Research Roundup: Polio mutation troubles, a pandemic bond, and Kenya's launch of a generic HIV drug

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Eric Becker
Research Roundup: The rise of drug-resistant TB, ecosystems and pandemics, and a UN-made global mosquito tracker

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Andrew Loxley, Court
Empowerment—the payoff of new HIV prevention tools for young women

Evidence shows that when women are both empowered and healthy, they are more likely to have healthy families, educate their children, and make positive social and economic contributions to society. New discreet and long-acting HIV prevention tools have the potential to empower women to protect their own health and unlock their potential.

Read More
PATH/Claire Suni
Research Roundup: Barriers to TB immunization, malaria's genetic diversity, and IPM's dapivirine ring

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Aaron Joel Santos
5 ways science is transforming global health and saving lives

Science expands our understanding, makes the impossible possible, and helps us build the future we want for all people. Science drives the work of GHTC, so we wanted to take a step back to reflect on five ways science is transforming global health.

Read More
PATH/Gabe Bienczycki
Research Roundup: Roadkill reveals new drugs, bracelet saves preemies, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Dunia Faulx
A year in review: The top stories in global health innovation that shaped 2016

As the year comes to an end, GHTC is reflecting on the top stories in global health innovation that made news 2016. 

GHTC
Read More
Architect of the Capitol
Research Roundup: HIV drug resistance, the 21st Century Cures Act, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Aaron Joel Santos
Research Roundup: A Zika treatment, an HIV cure, and a MERS vaccine

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
A cornucopia of thanks

In the spirit of the Thanksgiving holiday, GHTC asked our members and staff to share what they are most thankful for in global health.

Read More
National Institute of Allergy and Infectious Diseases
Research Roundup: Long-lasting pills, HIV testing, and starving bacteria of iron

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
National Institute of Allergy and Infectious Diseases
Research Roundup: Gene editing, mosquito takeover, and decoys for drug resistance

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
National Institute of Allergy and Infectious Diseases
Research Roundup: Flu vaccines, HIV in kids, and a cross-continental R&D partnership

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
International Partnership for Microbicides
Research Roundup: The HIV/AIDS and STIs edition

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Doune Porter
Research Roundup: Yellow fever vaccine availability, protective antibodies against HIV, and the impact of past dengue infection on Zika fever

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Research Roundup: legislation to expedite antibiotic R&D, a graduated approach to drug patents, and more

Scientists have described the first “teenage” broadly neutralizing antibody—an early stage version of the molecule, before developing the traits that make it effective against manifold HIV strains.

GHTC
Read More
A vaccine is essential to conclusively end HIV/AIDS: New modeling data catalyzes conversations around the end of HIV/AIDS and a vaccine’s role in getting there

In this guest post Tom Harmon, senior policy analyst at the International AIDS Vaccine Initiative (IAVI), highlights a new analysis exploring the critical role of a vaccine in ending AIDS.

Read More
Obama highlights global health and innovation in State of the Union

GHTC has long championed US leadership in global health and innovation, and we were encouraged to see President Barack Obama highlight these themes in his State of the Union address.

GHTC
Read More
365 review: Top global health innovation news of 2015

As 2015 draws to a close, the Global Health Technologies Coalition is reflecting on the past year in global health innovation.

GHTC
Read More
Transforming the lives of women and girls in sub-Saharan Africa and helping end AIDS through better HIV prevention research and development

In this guest post Tom Harmon, senior policy analyst at the International AIDS Vaccine Initiative (IAVI), and Anna Forbes, a globally recognized advocate for women’s HIV prevention needs, discuss a new piece proposing how HIV prevention research and development (R&D) for women and girls can better align with programs to improve their health and well-being.

Read More
Research Roundup: the first kid-friendly TB treatment, enlisting smartphones to diagnose malaria, and promising new microbicides

GHTC member TB Alliance announced last week the creation of the first-ever child-friendly tuberculosis (TB) medicines, which are currently undergoing regulatory review by the World Health Organization and should be available in early 2016.

GHTC
Read More
Research Roundup: Snakebites, TB and parasitic infections, and HIV/AIDS vaccine development

Snakebites, which Médecins Sans Frontières describes as “one of the world's most neglected public health emergencies,” kill 200,000 people each year.

GHTC
Read More
Research Roundup: tapeworm tumors, a new HIV/AIDS prevention method, and a TB test for low-resource settings

A recently released clinical report from the US Centers for Disease Control and Prevention details a case of a Colombian man who developed cancerous tumors on his lungs and liver that were comprised of tapeworm cells, rather than human cells.

GHTC
Read More
CDC/National Institute of Allergy and Infectious Diseases
Research Roundup: an aerosol TB vaccine, a new coating for HIV/AIDS drugs, drug-resistant malaria, and more

Researchers at Tulane University successfully tested an experimental aerosol tuberculosis (TB) vaccine in monkeys, demonstrating that the candidate was more effective in protecting against infection than BCG—the only TB vaccine on the market.

GHTC
Read More
CDC/Dr. Scott Smith
Research Roundup: an HIV/AIDS vaccine candidate, inflatable incubator for premature babies, and US government R&D

Dr. Robert Gallo co-discovered the HIV virus and subsequently led the development of the first HIV/AIDS blood test.

GHTC
Read More
PATH/Patrick McKern
Female condoms: the feel and shape of things to come

Take a stroll through any pharmacy and you’ll see shelves stacked with male condoms of many varieties, but look for a female condom and you aren't likely to find one for sale.

Read More
Advocacy and partnerships for HIV/AIDS prevention for women: A post from Durban, South Africa

Sitting halfway around the world from my office in Washington, DC, looking out my Durban hotel window at the Indian Ocean, I am reminded just how small and interconnected our world really is.

GHTC
Read More
Research Roundup: HIV/AIDS self-testing and advances in dengue fever and sleeping sickness R&D

A new study suggests that with basic training, individuals can learn to accurately and safely test themselves for HIV/AIDS.

GHTC
Read More
Research Roundup: a rapid diagnostic for three hemorrhagic fevers, a MERS vaccine to be tested in humans, and advances in R&D for HIV treatments

A new paper-based diagnostic can test for Ebola, dengue, and yellow fever in just ten minutes without running water, electricity, lab equipment, or highly-trained personnel.

GHTC
Read More
Research Roundup: a dengue vaccine, a breakthrough HIV treatment, antimicrobial R&D, and more

Later this year, French pharmaceutical company Sanofi plans to launch a vaccine for dengue fever, the first on the market for an infection for which nearly half of the world’s population is at risk.

GHTC
Read More
PATH/Gabe Bienczycki
How to accelerate innovation to solve the world's most urgent health issues

In this post, Amie Batson, MBA—chief strategy officer at GHTC member PATH—discusses a new PATH-led initiative to identify and showcase lifesaving innovations with the promise to transform global health by 2030 and offers insights into what it will take to accelerate the impact of innovation. This post originally appeared in the Innovation Countdown 2030 Report: Reimagining Global Health.

PATH
Read More
Research Roundup: bacteria-eating viruses, experimental HIV and flu vaccines, and pharmaceutical law

With the looming threat of a post-antibiotic era—in which minor infections are fatal due to growing drug resistance—world leaders are examining remedies for treating bacterial infections from the pre-antibiotic era.

GHTC
Read More
PATH/Nguyen Ba Quang
Research Roundup: Middle East Respiratory Syndrome R&D, G7 support for antimicrobial and neglected tropical disease R&D, patient safety and the 21st Century Cures Act, and the contraceptive pipeline

The zoonotic Middle East Respiratory Syndrome (MERS), which World Health Organization (WHO) Director-General Dr. Margaret Chan called “a threat to the entire world” has spread to South Korea. More than 100 cases and 10 deaths have been reported, making it the largest outbreak outside of the Arabian Peninsula.

GHTC
Read More
PATH/Evelyn Hockstein
Four reasons now is the time to ramp up investment in HIV/AIDS vaccine R&D

This Monday, May 18 was HIV Vaccine Awareness Day (HVAD), and GHTC members AVAC, the International AIDS Vaccine Initiative (IAVI), and the Bill & Melinda Gates Foundation convened leaders in the field to discuss the state of HIV/AIDS vaccine research and development (R&D).

GHTC
Read More
Mothers of innovation: Five mothers who have transformed global health

Breakthrough ideas are like children—they start small, they need constant nurturing, they don’t always develop according to schedule, but they change lives forever.

Read More
PATH/Patrick McKern
Research Roundup: publication of clinical trial results, the establishment of an African CDC, and more

The World Health Organization (WHO) released a statement last week calling for the publication of all data from clinical trials for drugs, vaccines, and medical devices.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: India to expand list of essential medicines, China’s emerging leadership in the pharmaceutical industry, WHO paves the way for hepatitis C generics, and more

India is expected to add all of the drugs currently used in the government’s HIV/AIDS and tuberculosis (TB) control programs to its list of essential medicines within the next six months.

GHTC
Read More
PATH/Patrick McKern
Research Roundup: Progress towards a vaccine for HIV, a rapid diagnostic and experimental drug for Ebola, and congressional support for global health research

A new compound has successfully protected monkeys from HIV, according to a study published in Nature last week.

GHTC
Read More
PATH/Evelyn Hockstein
Research Roundup: Experimental Ebola vaccines and treatments, HIV prevention research, and an 18-year high in drug approvals

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
HIV Vaccines and Microbicides Resource Tracking Working Group
First-ever conference devoted solely to HIV prevention R&D taking place in uncertain funding environment

Progress toward new tools to prevent HIV infection—including vaccines, microbicides, the use of antiretroviral treatment as HIV prevention, pre-exposure prophylaxis (PrEP), and a host of other options—is being presented and discussed at the inaugural HIV Research for Prevention Conference (HIVR4P) in Cape Town this week.

AVAC
Read More
PATH
Research Roundup: UNGA, public-private partnerships, new executive orders, neglected disease R&D grants, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Research Roundup: Congressional priorities, new HIV antibody, biomedical research funding, TB drug trial results, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Why invest in R&D for HIV, TB and malaria? Because it’s good for global health, and good for Europe

In this post, Eoghan Walsh—communications officer at Deutsche Stiftung Weltbevoelkerung (DSW)—writes about the need for Europe to increase financial and political support for efforts aimed at creating new ways to tackle diseases such as HIV/AIDS, tuberculosis (TB) and malaria.

Read More
Research Roundup: Appropriations, Ebola, AIDS 2014, open working groups, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Evelyn Hockstein
Research Roundup: Smart power, TB research, female condoms, HIV resource tracking, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
European and African countries meet to advance health technology development for poverty-related diseases

Earlier this week, Anne Hradský—advocacy coordinator for Global Health Research and Development (R&D), Katharina Scheffler—advocacy officer—and others from Deutsche Stiftung Weltbevoelkerung (DSW)—joined other European and African stakeholders for the Seventh European & Developing Countries Clinical Trials Partnerships (EDCTP) Forum in Berlin, Germany.

Read More
International Partnership for Microbicides
Research Roundup: Microbicides, hookworm vaccines, #MomAndBaby, pediatric HIV treatments, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
NIAID
Research Roundup: FY 2015 appropriations, the Human Vaccines Project, Global Development Lab legislation, new HIV treatments, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
EDCTP2: What it means for European support for global health R&D

In this guest post, Renate Baehr—executive director of Deutsche Stiftung Weltbevoelkerung—writes about the next rendition of the European & Developing Countries Clinical Trials Partnership (EDCTP) and how its expansion will impact more lives in low- and middle-income countries.

Read More
AVAC
Celebrating progress on World AIDS Vaccine Day

Yesterday, May 18, marked the observance of World AIDS Vaccine Day­­–an annual event to focus attention on the need for a vaccine to prevent HIV infection and AIDS.

Read More
PATH/Patrick McKern
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Matthew Dakin
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Will Boase
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Richard Franco
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
The end of AIDS requires increased commitments to research

In this guest post, Anupama Dathan—health research assistant for ONE—writes about a new report that examines global commitments to ending the AIDS pandemic.

ONE
Read More
The role of HIV research in ending AIDS: New developments in HIV vaccine and prevention science

In this guest post, Emily Donaldson—program coordinator at AVAC: Global Advocacy for HIV Prevention—writes about an upcoming congressional briefing on November 18 that will highlight the latest in HIV/AIDS research and development.

AVAC
Read More
New fact sheet outlines the global health R&D pipeline and why US support is so important

In the past, the United States has contributed to important breakthroughs in global health—from the eradication of smallpox to a 74 percent drop in measles deaths worldwide.

GHTC
Read More
PATH/Doune Porter
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Vaccinate against the brain drain

In this guest post, Elisabeth Wilhelm, senior media specialist at the International AIDS Vaccine Initiative (IAVI), writes about the need to invest in the next generation of researchers and scientists in sub-Saharan Africa.

Read More